作者: Ana S. Guerreiro , Danielle Boller , Tarek Shalaby , Michael A. Grotzer , Alexandre Arcaro
DOI: 10.1002/IJC.22126
关键词: Protein kinase B 、 Ribosomal protein s6 、 Cell growth 、 Growth factor receptor 、 Insulin-like growth factor 、 Cancer research 、 Insulin receptor 、 P70-S6 Kinase 1 、 Biology 、 Neuroblastoma
摘要: The potential of the novel insulin-like growth factor receptor (IGF-IR) inhibitor NVP-AEW541 as an antiproliferative agent in human neuroblastoma was investigated. Proliferation a panel cell lines inhibited by with IC50 values ranging from 0.15 to 5 μM. Experiments using IGF-IR neutralizing antibody confirmed that essential support lines. expression levels individual did not correlate sensitivities NVP-AEW541, while coexpression and insulin (IR) correlated lower sensitivity some Intriguingly, high activation Akt/protein kinase B (PKB) phosphorylation ribosomal S6 protein were observed decreased NVP-AEW541. Inhibition Akt/PKB activity restored cells inhibitor. Transfection activated Akt or (S6K) IGF-I-stimulated proliferation completely blocked combination phosphoinositide 3-kinase rapamycin. In addition its effects, sensitized cisplatin-induced apoptosis. Together, our data demonstrate inhibitors chemotherapeutic agents may represent approach target proliferation. © 2006 Wiley-Liss, Inc.